文献速递骨显像与常规 SPECT核素与放射性配体治疗

镭-223 SPECT半定量分析与锝-99m HMDP SPECT比较:体模研究与初步临床经验

Ra-223 SPECT for semi-quantitative analysis in comparison with Tc-99m HMDP SPECT: phantom study and initial clinical experience.
PubMed 文献 · EJNMMI Res · 2017-10-03

本研究通过体模实验确定镭-223 SPECT的准直器和能窗设置,并在10例去势抵抗性前列腺癌患者中比较镭-223 SPECT与锝-99m HMDP SPECT对骨转移灶的检测能力和半定量分析。结果显示高能通用准直器在84 keV ± 20%能窗下图像质量更优,镭-223 SPECT与锝-99m HMDP SPECT的病灶-本底比值呈正相关。作者推荐使用高能通用准直器在84 keV ± 20%条件下进行镭-223 SPECT显像。

要点

  • 体模研究确定高能通用准直器在84 keV ± 20%能窗下镭-223 SPECT图像质量更优。
  • 临床研究中高能通用准直器检出51个病灶,中能通用准直器检出36个(p=0.013)。
  • 镭-223 SPECT与锝-99m HMDP SPECT的病灶-本底比值呈正相关(r=0.67和0.69,p<0.01)。

核心结论

  • 作者推荐使用高能通用准直器在84 keV ± 20%条件下进行镭-223 SPECT显像。
  • 人体研究的病灶半定量分析显示,注射后早期(2-3小时)镭-223 SPECT与锝-99m HMDP SPECT之间具有良好的相关性。

研究设计与样本

  • 基础研究A:获取镭-223能谱和含热棒的圆柱体模SPECT图像,以确定适合临床镭-223 SPECT的准直器候选者和能窗设置。
  • 基础研究B:使用中能通用准直器和高能通用准直器扫描含管状腔室和两个模拟肠管活性及腰椎转移灶的球体的体模。
  • 临床研究:10例去势抵抗性前列腺癌患者,在镭-223注射后2小时随机顺序先后使用中能通用准直器和高能通用准直器进行SPECT显像,各30分钟。
  • 比较骨转移灶的病灶检出率和半定量分析(病灶-本底比值),对照锝-99m HMDP SPECT。

主要发现

  • 基础研究A显示,使用高能通用准直器在84 keV光电峰 ± 20%条件下提供的SPECT图像质量优于其他成像条件。
  • 基础研究B显示,平面显像中一个球体的摄取被管状腔室的活性重叠所高估,而SPECT中球体计数相似且球体-本底比值显著更高。
  • 平面显像和SPECT显像中,高能通用准直器的图像对比度均高于中能通用准直器(p < 0.01)。
  • 临床研究中,镭-223 SPECT在84 keV ± 20%条件下高能通用准直器检出的病灶数多于中能通用准直器(51 vs 36,p = 0.013)。
  • 锝-99m SPECT与镭-223 SPECT的病灶-本底比值呈正相关(中能通用准直器r = 0.67,高能通用准直器r = 0.69,p < 0.01);高能通用准直器的病灶-本底比值显著高于中能通用准直器(p < 0.01)。

关键数值与推荐

  • 体模研究确定高能通用准直器在84 keV ± 20%能窗下图像质量优于其他成像条件。
  • 临床研究采用镭-223 SPECT在84 keV ± 20%能窗下成像。
  • 半定量分析指标为病灶-本底比值。

临床怎么用

  • 作者推荐使用高能通用准直器在84 keV ± 20%条件下进行镭-223 SPECT显像。
  • 人体研究的病灶半定量分析显示,注射后早期(2-3小时)镭-223 SPECT与锝-99m HMDP SPECT之间具有良好的相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Image-based measurement of absorbed dose of Ra-223 dichloride may be useful in predicting therapeutic outcome in patients with castration-resistant prostate cancer (CRPC). In general, SPECT has been found to be more accurate than planar imaging in terms of lesion-based analysis. The aims of this study were to assess the feasibility and clinical usefulness of Ra-223 SPECT. The energy spectrum of Ra-223 and SPECT images of a cylindrical phantom with a hot rod were obtained to determine the collimator candidates and energy window settings suitable for clinical Ra-223 SPECT (basic study A). Another phantom with a tube-shaped chamber and two spheres simulating bowel activity and metastatic lesions in the lumbar spine was scanned with medium-energy general-purpose (MEGP) and high-energy general-purpose (HEGP) collimators (basic study B). Ten patients with CRPC underwent SPECT imaging 2 h after Ra-223 injection successively with MEGP and HEGP collimators in random order for 30 min each. Lesion detectability and semi-quantitative analyses of bone metastasis (i.e. lesion-to-background ratio (LBR)) were performed compared to Tc-99m HMDP SPECT. RESULTS: Basic study A revealed that an 84-keV photopeak ± 20% using the HEGP collimator offers better SPECT image quality than the other imaging conditions. Basic study B showed that uptake in one of the spheres was overestimated by overlapped activity of the tube-shaped chamber in planar imaging whereas the spheres had similar counts and significantly higher sphere-to-background ratio in SPECT. On both planar and SPECT images, HEGP gave higher image contrast than MEGP (p < 0.01). In the clinical study, Ra-223 SPECT at 84 keV ± 20% depicted more lesions with the HEGP than with the MEGP collimator (51 vs 36, p = 0.013). There was a positive correlation between LBR in Tc-99m SPECT and in Ra-223 SPECT (r = 0.67 with the MEGP and 0.69 with the HEGP collimator, p < 0.01). LBRs were significantly higher with the HEGP than with the MEGP collimator (p < 0.01). CONCLUSIONS: We recommended the use of the HEGP collimator at 84 keV ± 20% for Ra-223 SPECT imaging. Lesion-based semi-quantitative analysis in the human study revealed a good correlation between Ra-223 and Tc-99m HMDP SPECT in the early phase (2-3 h post injection).

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Owaki Y, Nakahara T, Kosaka T, et al. Ra-223 SPECT for semi-quantitative analysis in comparison with Tc-99m HMDP SPECT: phantom study and initial clinical experience. EJNMMI Res. 2017. PMID: 28975570. doi:10.1186/s13550-017-0330-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。